Early estimates of seasonal influenza vaccine effectiveness — United States, January 2015

Morbidity and Mortality Weekly Report

Volumn 64, Issue 1, 2015, Pages 10-15

  Flannery, Brendan ^a   Clippard, Jessie ^a   Zimmerman, Richard K ^b   Nowalk, Mary Patricia ^b   Jackson, Michael L ^c   Jackson, Lisa A ^c   Monto, Arnold S ^d   Petrie, Joshua G ^d   McLean, Huong Q ^e   Belongia, Edward A ^e   Gaglani, Manjusha ^f   Berman, LaShondra ^a   Foust, Angie ^a   Sessions, Wendy ^a   Thaker, Swathi N ^a   Spencer, Sarah ^a   Fry, Alicia M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e MARSHFIELD CLINIC   (United States)

^f TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOLOGY; INFANT; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTIONS; SEASON; STATISTICS AND NUMERICAL DATA; UNITED STATES; VACCINATION; VIROLOGY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; SEASONS; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 84922473579     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (9)

1. Grohskopf LA, Olsen SJ, Sokolow LZ, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2014-15 influenza season. Morb Mortal Wkly Rep 2014; 63: 691-7.
2. CDC. Fluview. 2014-2015 influenza season week 53 ending January 3, 2015. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. Available at http://www. cdc. gov/flu/weekly.
3. Fry AM, Kim IK, Reed C, et al. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults. Clin Infect Dis 2014; 59: 406-9.
4. CDC. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60(No. RR-1).
5. McLean HQ, Thompson MG, Sundaram ME, et al. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis 2014. Epub ahead of print.
6. Fry AM, Goswami D, Nahar K, et al. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial. Lancet Infect Dis 2014; 14: 109-18.
7. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 36-44.
8. Rolfes M, Blanton L, Brammer L, et al. Update: influenza activity-United States, September 28-December 6, 2014. MMWR Morb Mortal Wkly Rep 2014; 63: 1189-94.
9. Blanton L, Brammer L, Smith S, et al. Update: influenza activity-United States and worldwide, May 18-September 20, 2014. MMWR Morb Mortal Wkly Rep 2014; 63: 861-4.